6066.HK
6066.HK
CNE100002B89
CSC
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 45/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.6x).

Beta (Market Relation)
0.6x
Defensive
Volatility (5Y p.a.)
48.4% p.a.
5-Year Horizon
Max Drawdown (5Y)
-54.4%
5-Year Horizon
Sharpe Ratio
0.05
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Volatility Expansion (3Y > 5Y) High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -19.6%
3 Years 55.6% -54.4% 0.21 +14.1%
5 Years 48.4% -54.4% 0.05 +5%
10 Years 44.4% -61.7% 0.06 —

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 311%.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Elevated Short-Term Volatility: 3Y volatility (55.6%) is noticeably higher than the 5Y average (48.4%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (48.4% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -61.7% in the extended horizon.
ende